NCT03734081View on ClinicalTrials.gov

Safety and Feasibility Assessment of the Bio-electrical One Day Capsule System in Overweight and Class I Obese Participants

NASuspendedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 4, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

March 31, 2020

Conditions
Overweight and Obesity
Interventions
DEVICE

ODC system (type 1 capsule)

ODC (one day capsule) type 1 is ingested by a subject and passes through the gastrointestinal tract. Electrical stimulation is the transferred from the capsule to the surrounding GI tissues. The capsule is excreted from the body through the intestinal tract in a natural manner with bowel movement.

DEVICE

ODC system (type 2 capsule)

ODC (one day capsule) type 2 is ingested by a subject and passes through the gastrointestinal tract. Electrical stimulation is the transferred from the capsule to the surrounding GI tissues. The capsule is excreted from the body through the intestinal tract in a natural manner with bowel movement.

Trial Locations (1)

4428164

Meir Medical Center, Kfar Saba

Sponsors
All Listed Sponsors
lead

Melcap Systems Ltd.

INDUSTRY